![](/content/dam/SHC/doctors-medicalstaff/d/dirbas-frederick-md.jpg/_jcr_content/renditions/original.transform/280x280-q76/image.jpg)
![Frederick M. Dirbas, MD](/content/dam/SHC/doctors-medicalstaff/d/dirbas-frederick-md.jpg/_jcr_content/renditions/original.transform/280x280-q76/image.jpg)
Biography
Professional Summary
Education & Certifications
- Residency: Stanford University Dept of General Surgery (1992) CA
- Fellowship: Stanford University Dept of Surgery (1994) CA
- Fellowship: National Institute of Health (1989) MD
- Medical Education: Columbia University Office of the Registrar (1985) NY
- Board Certification: American Board of Surgery, General Surgery (1994)
- MD, Columbia University College of Physicians and Surgeons (1985)
- BS with Honors, Stanford University, Chemistry (1981)
Honors & Awards
- America's Top Oncologists, Consumers' Research Council of America (2009)
- America's Top Surgeons, Consumers' Research Council of America (2010)
- Best Doctors in America, Best Doctors, Inc (2012)
- Best Doctors in America, Best Doctors, Inc (2017)
- Best Doctors in America, Best Doctors, Inc (2018)
- Best Doctors in America, Best Doctors, Inc (2019)
- Best Doctors in America, Best Doctors, Inc (2021)
- Best Doctors in America, Best Doctors, Inc. (2009)
- Best Doctors in America, Best Doctors, Inc. (2010)
- Best Doctors in America, Best Doctors, Inc. (2011)
- Best Doctors in America, Best Doctors, Inc. (2013)
- Best Doctors in America, Best Doctors, Inc. (2014)
- Best Doctors in America, Best Doctors, Inc. (2015)
- Best Doctors in America, Best Doctors, Inc. (2016)
- Best Doctors in America, Best Doctors, Inc. (2020)
- Best Doctors in America, Best Doctors, Inc. (2022)
- Best Doctors in America, Best Doctors, Inc. (2023)
- Grant Recipient, Vadasz Foundation (2004)
- IORT for Breast Cancer (http://www.msnbc.msn.com/id/6503963/ns/nightly_news/), NBC (2004)
- Star Caregiver Award, Silicon Valley Wellness Foundation (2008)
- Top Doctors, Castle Connolly (2017)
- Top Doctors, Castle Connolly (2018)
- Top Doctors, Castle Connolly (2020)
- Top Doctors, Castle Connolly (2021)
- Top Doctors, Castle Connolly (2022)
- Top Doctors, Castle Connolly (2023)
- Top Doctors, Catle Connolly (2019)
Memberships
- Chair, Scientific Advisory Board, Beyond Cancer, Ltd (2023 - Present)
- Medical Advisory Board, Silicon Valley Innovations, NasoClenz (2021 - Present)
- Board of Directors, School of Oncoplastic Surgery (2020 - Present)
Administrative Appointments
- Co-Chair, Tissue Committee, Stanford Health Care (2019 - Present)
- Co-Leader, Breast Cancer Clinical Research Group, Stanford Cancer Center, Stanford University School of Medicine, Stanford Hospital (2011 - 2015)
- Director, Clinical Care Sub-team, Breast Disease Management Group, Stanford Cancer Center (2006 - 2010)
- Physician Leader, Breast Cancer Clinical Care Program (CCP), Stanford Cancer Center, Stanford University School of Medicine, Stanford Hospital (2010 - 2017)
Publications
-
Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi
Purcell, G. P., Dirbas, F. M., Jeffrey, R. B., Lane, M. J., Desser, T., McDougall, R., & Weigel, R. J. (1999). Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi. ARCHIVES OF SURGERY, 134(8), 824–28. -
Radiofrequency ablation of breast cancer - First report of an emerging technology
Jeffrey, S. S., Birdwell, R. L., Ikeda, D. M., Daniel, B. L., Nowels, K. W., Dirbas, F. M., & Griffey, S. M. (1999). Radiofrequency ablation of breast cancer - First report of an emerging technology. ARCHIVES OF SURGERY, 134(10), 1064–68. -
Locally advanced breast cancer: is surgery necessary?
Favret, A. M., Carlson, R. W., Goffinet, D. R., Jeffrey, S. S., Dirbas, F. M., & Stockdale, F. E. (2001). Locally advanced breast cancer: is surgery necessary? Breast Journal, 7(2), 131–137. -
Freehand iMRI-guided large-gauge core needle biopsy: A new minimally invasive technique for diagnosis of enhancing breast lesions
Daniel, B. L., Birdwell, R. L., Butts, K., Nowels, K. W., Ikeda, D. M., Heiss, S. G., … Herfkens, R. J. (2001). Freehand iMRI-guided large-gauge core needle biopsy: A new minimally invasive technique for diagnosis of enhancing breast lesions. JOURNAL OF MAGNETIC RESONANCE IMAGING. PHILADELPHIA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA,PA: JOHN WILEY & SONS INC. -
-
PROLONGATION OF GRAFT-SURVIVAL IN PRIMATE ALLOGRAFT TRANSPLANTATION BY YTTRIUM-90-LABELED ANTI-TAC IN CONJUNCTION WITH GRANULOCYTE COLONY-STIMULATING FACTOR
Parenteau, G. L., Dirbas, F. M., Garmestani, K., Brechbiel, M. W., BUKOWSKI, M. A., Goldman, C. K., … Waldmann, T. A. (1992). PROLONGATION OF GRAFT-SURVIVAL IN PRIMATE ALLOGRAFT TRANSPLANTATION BY YTTRIUM-90-LABELED ANTI-TAC IN CONJUNCTION WITH GRANULOCYTE COLONY-STIMULATING FACTOR. TRANSPLANTATION, 54(6), 963–968. -
Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma
Hartman, A. R., Daniel, B. L., Kurian, A. W., Mills, M. A., Nowels, K. W., Dirbas, F. M., … Plevritis, S. K. (2004). Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma. CANCER, 100(3), 479–489. -
Magnetic resonance imaging of suspicious breast masses seen on one mammographic view.
Offodile, R. S., Daniel, B. L., Jeffrey, S. S., Wapnir, I., Dirbas, F. M., & Ikeda, D. M. (2004). Magnetic resonance imaging of suspicious breast masses seen on one mammographic view. Breast Journal, 10(5), 416–22. -
The evolution of accelerated, partial breast irradiation as a potential treatment option for women with newly diagnosed breast cancer considering breast conservation
Dirbas, F. M., Jeffrey, S. S., & Goffinet, D. R. (2004). The evolution of accelerated, partial breast irradiation as a potential treatment option for women with newly diagnosed breast cancer considering breast conservation. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 19(6), 673–705. -
Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization
Wallace, A. M., Daniel, B. L., Jeffrey, S. S., Birdwell, R. L., Nowels, K. W., Dirbas, F. M., … Ikeda, D. M. (2005). Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 200(4), 527–37. -
Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy?
Langer, S. A., Horst, K. C., Ikeda, D. M., Daniel, B. L., Kong, C. S., & Dirbas, F. M. (2005). Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy? AMERICAN JOURNAL OF SURGERY. LOS ANGELES,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA,CA: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC. -
Streamlining clinical breast examination
Goodson, W. H., Grissom, N. A., Moore, D. H., & Dirbas, F. M. (2005). Streamlining clinical breast examination. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 97(19), 1476–77. -
-
-
-
New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
Kohrt, H. E., Olshen, R. A., Bermas, H. R., Goodson, W. H., Wood, D. J., Henry, S., … Jeffrey, S. S. (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC CANCER, 8. -
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., … Clarke, M. F. (2009). Association of reactive oxygen species levels and radioresistance in cancer stem cells. NATURE, 458(7239), 780–U123. -
Accelerated Partial Breast Irradiation: Where Do We Stand?
Dirbas, F. M. (2009). Accelerated Partial Breast Irradiation: Where Do We Stand? JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 7(2), 215–25. -
-
-
3.0-T MR-Guided Focused Ultrasound for Preoperative Localization of Nonpalpable Breast Lesions: An Initial Experimental Ex Vivo Study
Schmitz, A. C., Van den Bosch, M. A. A. J., Rieke, V., Dirbas, F. M., Pauly, K. B., Mali, W. P. T. M., & Daniel, B. L. (2009). 3.0-T MR-Guided Focused Ultrasound for Preoperative Localization of Nonpalpable Breast Lesions: An Initial Experimental Ex Vivo Study. JOURNAL OF MAGNETIC RESONANCE IMAGING, 30(4), 884–889. -
ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR, PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL
Brown, P. S., Parenteau, G. L., Dirbas, F. M., Garsia, R. J., Goldman, C. K., BUKOWSKI, M. A., … Waldmann, T. A. (1991). ANTI-TAC-H, A HUMANIZED ANTIBODY TO THE INTERLEUKIN-2 RECEPTOR, PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 88(7), 2663–2667. -
Freehand MRI-Guided Preoperative Needle Localization of Breast Lesions After MRI-Guided Vacuum-Assisted Core Needle Biopsy Without Marker Placement
van de Ven, S. M. W. Y., Lin, M. C., Daniel, B. L., Sareen, P., Lipson, J. A., Pal, S., … Ikeda, D. M. (2010). Freehand MRI-Guided Preoperative Needle Localization of Breast Lesions After MRI-Guided Vacuum-Assisted Core Needle Biopsy Without Marker Placement. JOURNAL OF MAGNETIC RESONANCE IMAGING, 32(1), 101–9. -
-
DISSEMINATED CUTANEOUS HERPES-ZOSTER FOLLOWING CARDIAC-SURGERY
Dirbas, F. M., & Swain, J. A. (1990). DISSEMINATED CUTANEOUS HERPES-ZOSTER FOLLOWING CARDIAC-SURGERY. JOURNAL OF CARDIOVASCULAR SURGERY, 31(4), 531–532. -
Toward MR-guided high intensity focused ultrasound for presurgical localization: Focused ultrasound lesions in cadaveric breast tissue
Bitton, R. R., Kaye, E., Dirbas, F. M., Daniel, B. L., & Pauly, K. B. (2012). Toward MR-guided high intensity focused ultrasound for presurgical localization: Focused ultrasound lesions in cadaveric breast tissue. JOURNAL OF MAGNETIC RESONANCE IMAGING, 35(5), 1089–97. -
A Pilot Cohort Study of the Determinants of Longitudinal Opioid Use After Surgery
Carroll, I., Barelka, P., Wang, C. K. M., Wang, B. M., Gillespie, M. J., McCue, R., … Mackey, S. C. (2012). A Pilot Cohort Study of the Determinants of Longitudinal Opioid Use After Surgery. ANESTHESIA AND ANALGESIA, 115(3), 694–702. -
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients
Zuckerman, N. S., Yu, H., Simons, D. L., Bhattacharya, N., Carcamo-Cavazos, V., Yan, N., … Lee, P. P. (2013). Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients. INTERNATIONAL JOURNAL OF CANCER, 132(11), 2537–47. -
PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ
Yu, H., Simons, D. L., Segall, I., Carcamo-Cavazos, V., Schwartz, E. J., Yan, N., … Lee, P. P. (2012). PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ. PLOS ONE, 7(12). -
Breast magnetic resonance imaging alters patient selection for accelerated partial breast irradiation.
Horst, K. C., Ikeda, D. M., Fero, K. E., Daniel, B. L., Goffinet, D. R., & Dirbas, F. M. (2014). Breast magnetic resonance imaging alters patient selection for accelerated partial breast irradiation. American Journal of Clinical Oncology, 37(3), 248–54. -
Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.
Horst, K. C., Fero, K. E., Ikeda, D. M., Daniel, B. L., & Dirbas, F. M. (2013). Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation. Radiotherapy and Oncology , 108(2), 220–25. -
CONTROLLED REPERFUSION FOLLOWING REGIONAL ISCHEMIA
Lazar, H. L., Wei, J., Dirbas, F. M., Haasler, G. B., & Spotnitz, H. M. (1987). CONTROLLED REPERFUSION FOLLOWING REGIONAL ISCHEMIA. ANNALS OF THORACIC SURGERY, 44(4), 350–355. -
EXPERIMENTS ON THE ABIOTIC AMPLIFICATION OF OPTICAL-ACTIVITY
Bonner, W. A., Blair, N. E., & Dirbas, F. M. (1981). EXPERIMENTS ON THE ABIOTIC AMPLIFICATION OF OPTICAL-ACTIVITY. ORIGINS OF LIFE AND EVOLUTION OF BIOSPHERES, 11(1-2), 119–134. -
HUMANIZED ANTIBODY-DIRECTED TO THE IL-2 RECEPTOR BETA-CHAIN PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL
TINUBU, S. A., Hakimi, J., KONDAS, J. A., Bailon, P., Familletti, P. C., Spence, C., … Waldmann, T. A. (1994). HUMANIZED ANTIBODY-DIRECTED TO THE IL-2 RECEPTOR BETA-CHAIN PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL. JOURNAL OF IMMUNOLOGY, 153(9), 4330–4338. -
Perforated jejunal diverticula
Koger, K. E., Shatney, C. H., Dirbas, F. M., & McClenathan, J. H. (1996). Perforated jejunal diverticula. AMERICAN SURGEON, 62(1), 26–29. -
Breast Surgical Techniques and Interdisciplinary Management
(2011). Breast Surgical Techniques and Interdisciplinary Management, Springer. -
Comprehensive screening using breast MRI and ductal lavage in high-risk women.
Hartman, A. R., Daniel, B. L., Ford, J. M., Chun, N. M., Kingham, K. E., Mills, M. A., … Plevritis, S. K. (2002). Comprehensive screening using breast MRI and ductal lavage in high-risk women. Presented at the 25th San Antonio Breast Cancer Symposium, SAN ANTONIO,TX,TX,TX,TX: SPRINGER. -
Results from a pilot breast cancer screening trial using a combination of clincal breast exam, mammography, breast MRI, and ductal lavage in a high-risk population
Hartman, A. R., Kurian, A., Mills, M. A., Daniel, B. L., Ford, J. M., Kingham, K. E., … Plevritis, S. K. (2003). Results from a pilot breast cancer screening trial using a combination of clincal breast exam, mammography, breast MRI, and ductal lavage in a high-risk population. Presented at the 26th Annual San Antonio Breast Cancer Symposium, SAN ANTONIO,TX,TX,TX,TX: SPRINGER. -
A pilot breast cancer screening trial for women at high inherited risk using clinical breast exam, mammography, breast magnetic resonance imaging, and ductal lavage: updated results after median follow-up of fourteen months.
Kurian, A. W., Daniel, B. L., Mills, M. A., Nowels, K. W., Ford, J. M., Plevritis, S. K., … Hartman, A. R. (2004). A pilot breast cancer screening trial for women at high inherited risk using clinical breast exam, mammography, breast magnetic resonance imaging, and ductal lavage: updated results after median follow-up of fourteen months. Presented at the 27th Annual San Antonio Breast Cancer Symposium, SAN ANTONIO,TX,TX,TX,TX: SPRINGER. -
Predicting non-sentinel lymph node involvement in breast cancer patients.
Kohrt, H. E., Olshen, R. A., Goodson, W. H., Rouse, R. V., Bailey, L., Philben, V., … Jeffrey, S. S. (2006). Predicting non-sentinel lymph node involvement in breast cancer patients. JOURNAL OF CLINICAL ONCOLOGY, 24(18), 10S–10S. -
New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients
Kohrt, H., Olshen, R., Bermas, H., GOODSON, W., Henry, S., Rouse, R., … JEFFREY, S. (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BREAST CANCER RESEARCH AND TREATMENT, 109(3), 588–88. -
CONTROLLED REPERFUSION OF REGIONAL ISCHEMIA
Lazar, H. L., Wei, J., Dirbas, F. M., & Spotnitz, H. M. (1983). CONTROLLED REPERFUSION OF REGIONAL ISCHEMIA. SURGICAL FORUM, 34, 257–258. -
STEREOSELECTIVE HYDROLYSIS OF LEUCINE OLIGOMERS
Blair, N. E., Dirbas, F. M., & Bonner, W. A. (1981). STEREOSELECTIVE HYDROLYSIS OF LEUCINE OLIGOMERS. TETRAHEDRON, 37(1), 27–29. -
Breast magnetic resonance imaging alters patient selection for accelerated, partial breast irradiation
Horst, K. C., Ikeda, D. M., Birdwell, R. L., Daniel, B. L., Goffinet, D. R., Pal, S., … Dirbas, F. M. (2005). Breast magnetic resonance imaging alters patient selection for accelerated, partial breast irradiation. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. DENVER,CO,CO: ELSEVIER SCIENCE INC. -
A simplified clinical breast examination will work.
Goodson, W. H., Dirbas, F. M., Grissom, N. A., & Moore, D. H. (2004). A simplified clinical breast examination will work. Presented at the 27th Annual San Antonio Breast Cancer Symposium, SAN ANTONIO,TX: SPRINGER. -
Survival analysis of women with double primary breast and ovarian carcinomas
Liou, W. S., Cheung, M. K., Hamilton, C., Osann, K., Dirbas, F., & Chan, J. K. (2005). Survival analysis of women with double primary breast and ovarian carcinomas. OBSTETRICS AND GYNECOLOGY, 105(4), 86S–86S. -
Axillary surgery in breast cancer patients
Millet, A., FUSTER, C. A., Lluch, A., & Dirbas, F. (2007). Axillary surgery in breast cancer patients. CLINICAL & TRANSLATIONAL ONCOLOGY, 9(8), 513–520. -
Breast Magnetic Resonance Imaging Alters Patient Selection for Accelerated Partial Breast Irradiation
Horst, K. C., Ikeda, D. M., Fero, K. E., Daniel, B. L., Goffinet, D. R., & Dirbas, F. M. (2014). Breast Magnetic Resonance Imaging Alters Patient Selection for Accelerated Partial Breast Irradiation. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 37(3), 248–54. -
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition
Zhang, H., Cohen, A. L., Krishnakumar, S., Wapnir, I. L., Veeriah, S., Deng, G., … Jeffrey, S. S. (2014). Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition. BREAST CANCER RESEARCH, 16(2). -
-
-
miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.
Isobe, T., Hisamori, S., Hogan, D. J., Zabala, M., Hendrickson, D. G., Dalerba, P., … Shimono, Y. (2014). miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. ELife, 3. -
-
A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis.
Scheeren, F. A., Kuo, A. H., van Weele, L. J., Cai, S., Glykofridis, I., Sikandar, S. S., … Clarke, M. F. (2014). A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. Nature Cell Biology, 16(12), 1238–48. -
-
Pain Duration and Resolution following Surgery: An Inception Cohort Study.
Carroll, I. R., Hah, J. M., Barelka, P. L., Wang, C. K. M., Wang, B. M., Gillespie, M. J., … Mackey, S. C. (2015). Pain Duration and Resolution following Surgery: An Inception Cohort Study. Pain Medicine , 16(12), 2386–2396. -
-
Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer
Horst, K. C., Fasola, C., Ikeda, D., Daniel, B., Ognibene, G., Goffinet, D. R., & Dirbas, F. M. (2016). Five-year results of a prospective clinical trial investigating accelerated partial breast irradiation using 3D conformal radiotherapy after lumpectomy for early stage breast cancer. BREAST, 28, 178–83. -
CT-Guided Wire Localization for Involved Axillary Lymph Nodes After Neo-adjuvant Chemotherapy in Patients With Initially Node-Positive Breast Cancer
Long Trinh, L., Miyake, K. K., Dirbas, F. M., Kothary, N., Horst, K. C., Lipson, J. A., … Ikeda, D. M. (2016). CT-Guided Wire Localization for Involved Axillary Lymph Nodes After Neo-adjuvant Chemotherapy in Patients With Initially Node-Positive Breast Cancer. BREAST JOURNAL, 22(4), 390–96. -
Breast Cancer After Hodgkin Lymphoma: The Price of Success.
Manzo, V., Dirbas, F., & Telli, M. L. (2016). Breast Cancer After Hodgkin Lymphoma: The Price of Success. Oncology (Williston Park, N.Y.), 30(12). -
IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer.
Wang, L., Miyahira, A. K., Simons, D. L., Lu, X., Chang, A. Y., Wang, C., … Lee, P. P. (2017). IL6 Signaling in Peripheral Blood T Cells Predicts Clinical Outcome in Breast Cancer. Cancer Research, 77(5), 1119–26. -
Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center
Porter, J. B. (2017). Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center. Improving Care With a Portfolio of Physician-Led Cancer Quality Measures at an Academic Center, 13(8), e673–e682. -
Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis.
Sikandar, S. S., Kuo, A. H., Kalisky, T., Cai, S., Zabala, M., Hsieh, R. W., … Clarke, M. F. (2017). Role of epithelial to mesenchymal transition associated genes in mammary gland regeneration and breast tumorigenesis. Nature Communications, 8(1), 1669. -
Optimized imaging of the growth and metastasis of human breast cancer stem cells in immunodeficient mice
Liu, H., Patel, M., Prescher, J., Qian, D., Dalerba, P., Lin, J., … Clarke, M. (2009). Optimized imaging of the growth and metastasis of human breast cancer stem cells in immunodeficient mice. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
Beausang, J. F., Wheeler, A. J., Chan, N. H., Hanft, V. R., Dirbas, F. M., Jeffrey, S. S., & Quake, S. R. (2017). T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire. Proceedings of the National Academy of Sciences of the United States of America. -
Image-Guided Breast Biopsy
Chandra, V., Dirbas, F. M., & Ikeda, D. M. (2011). Image-Guided Breast Biopsy. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 223–40. -
Identification of cytokine network signaling abnormalities in immune cells from cancer patients.
Miyahira, A. K., Simons, D. L., Dirbas, F., Guardino, E., Sheth, S., Carlson, R., & Lee, P. P. (2013). Identification of cytokine network signaling abnormalities in immune cells from cancer patients. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Introduction to Gene Expression Profiling in Breast Cancer
Dirbas, F. M., & Sotiriou, C. (2011). Introduction to Gene Expression Profiling in Breast Cancer. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 295–314. -
Office-Based Diagnostic Procedures
Chow, C. E., & Dirbas, F. M. (2011). Office-Based Diagnostic Procedures. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 211–22. -
Clinical Management of Breast Pain
Millet, A. V., Leal, A., & Dirbas, F. M. (2011). Clinical Management of Breast Pain. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 147–53. -
National trends in mastectomy for operable breast cancers treated with neoadjuvant chemotherapy
Pollom, E., Qian, Y., Dirbas, F., Horst, K., & Tsai, C. J. (2018). National trends in mastectomy for operable breast cancers treated with neoadjuvant chemotherapy. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Accelerated, Partial Breast Irradiation Overview
Wheeler, A. J., Dirbas, F. M., & Horst, K. C. (2011). Accelerated, Partial Breast Irradiation Overview. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 829–36. -
Accelerated, Partial Breast Irradiation with Intraoperative Radiotherapy
Baynosa, J., Horst, K. C., & Dirbas, F. M. (2011). Accelerated, Partial Breast Irradiation with Intraoperative Radiotherapy. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 883–97. -
Breast Imaging Following Breast Conservation Therapy
Gutierrez, R., Horst, K. C., Dirbas, F. M., & Ikeda, D. M. (2011). Breast Imaging Following Breast Conservation Therapy. BREAST SURGICAL TECHNIQUES AND INTERDISCIPLINARY MANAGEMENT, 975–95. -
Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy.
Pollom, E. L., Qian, Y., Chin, A. L., Dirbas, F. M., Asch, S. M., Kurian, A. W., … Tsai, C. J. (2018). Rising rates of bilateral mastectomy with reconstruction following neoadjuvant chemotherapy. International Journal of Cancer. -
The DLK1-DIO3 imprinted region regulates long-term proliferation in normal and malignant breast epithelium
Zabala, M., Lobo, N. A., Seoane, J. A., Stelzer, Y., Luong, A. V., Isobe, T., … Clarke, M. F. (2018). The DLK1-DIO3 imprinted region regulates long-term proliferation in normal and malignant breast epithelium. MOLECULAR CANCER RESEARCH, 16(8), 95. -
Mastalgia (breast pain)
Millet, A. V., & Dirbas, F. M. (2007). Mastalgia (breast pain). CAMBRIDGE HANDBOOK OF PSYCHOLOGY, HEALTH AND MEDICINE, 2ND EDITION, 774–76. -
-
T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire
Beausang, J. F., Wheeler, A. J., Chan, N. H., Hanft, V. R., Dirbas, F. M., Jeffrey, S. S., & Quake, S. R. (2017). T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 114(48), E10409–E10417. -
Single-cell transcriptional diversity is a hallmark of developmental potential.
Gulati, G. S., Sikandar, S. S., Wesche, D. J., Manjunath, A., Bharadwaj, A., Berger, M. J., … Newman, A. M. (2020). Single-cell transcriptional diversity is a hallmark of developmental potential. Science (New York, N.Y.), 367(6476), 405–11. -
Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes.
Wang, L., Simons, D. L., Lu, X., Tu, T. Y., Avalos, C., Chang, A. Y., … Lee, P. P. (2020). Breast cancer induces systemic immune changes on cytokine signaling in peripheral blood monocytes and lymphocytes. EBioMedicine, 52, 102631. -
A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS)
Wapnir, I., DeMartini, W., Allison, K., Stone, K., Dirbas, F., Marquez, C., … Horst, K. (2020). A randomized phase II study comparing surgical excision versus NeOadjuvant Radiotherapy followed by delayed surgical excision of Ductal carcinoma In Situ (NORDIS). CANCER RESEARCH. AMER ASSOC CANCER RESEARCH. -
Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
Kozak, M. M., Horst, K. C., Gutkin, P. M., Jacobson, C. E., Walck, E., von Eyben, R., & Dirbas, F. M. (2020). Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery. Clinical Breast Cancer. -
LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis.
Zabala, M., Lobo, N. A., Antony, J., Heitink, L. S., Gulati, G. S., Lam, J., … Clarke, M. F. (2020). LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis. Cell Stem Cell. -
Impact of mastectomy for breast cancer on spinal curvature: Considerations when treating patients with scoliosis.
Gutkin, P. M., Kapp, D. S., von Eyben, R., Dirbas, F. M., & Horst, K. C. (2020). Impact of mastectomy for breast cancer on spinal curvature: Considerations when treating patients with scoliosis. The Breast Journal. -
Development of a Classification Tree to Predict Implant-Based Reconstruction Failure with or without Postmastectomy Radiation Therapy for Breast Cancer.
Chen, J. J., von Eyben, R., Gutkin, P. M., Hawley, E., Dirbas, F. M., Lee, G. K., & Horst, K. C. (2020). Development of a Classification Tree to Predict Implant-Based Reconstruction Failure with or without Postmastectomy Radiation Therapy for Breast Cancer. Annals of Surgical Oncology. -
Angiosarcoma of the Breast: Management and Outcomes.
Gutkin, P. M., Ganjoo, K. N., Lohman, M., von Eyben, R., Charville, G. W., Nazerali, R. S., … Horst, K. C. (2020). Angiosarcoma of the Breast: Management and Outcomes. American Journal of Clinical Oncology. -
Two Patient Studies of a Companion Diagnostic Immuno-Positron Emission Tomography (PET) Tracer for Measuring Human CA6 Expression in Cancer for Antibody Drug Conjugate (ADC) Therapy.
Natarajan, A., Srinivas, S. M., Azevedo, C., Greene, L., Bauchet, A.-L., Jouannot, E., … Gambhir, S. S. (2020). Two Patient Studies of a Companion Diagnostic Immuno-Positron Emission Tomography (PET) Tracer for Measuring Human CA6 Expression in Cancer for Antibody Drug Conjugate (ADC) Therapy. Molecular Imaging, 19, 1536012120939398. -
Preoperative Factors Associated with Remote Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: Post Hoc Analysis of a Perioperative Gabapentin Trial.
Hah, J. M., Hilmoe, H., Schmidt, P., McCue, R., Trafton, J., Clay, D., … Carroll, I. (2020). Preoperative Factors Associated with Remote Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: Post Hoc Analysis of a Perioperative Gabapentin Trial. Journal of Pain Research, 13, 2959–70. -
Impact of COVID-19 on breast cancer care at a Bay Area academic center
Wu, J., Bobo, S., Henry, S., Mills, M., Kurian, A., & Dirbas, F. (2021). Impact of COVID-19 on breast cancer care at a Bay Area academic center. CANCER RESEARCH, 81(4). -
Return to work and productivity loss after surgery: A health economic evaluation.
M Hah, J., Lee, E., Shrestha, R., Pirrotta, L., Huddleston, J., Goodman, S., … Schofield, D. (2021). Return to work and productivity loss after surgery: A health economic evaluation. International Journal of Surgery (London, England), 106100. -
Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018)
Hah, J., Mackey, S. C., & Schmidt, P. (2022). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018). JAMA SURGERY. -
Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018)
Hah, J., Mackey, S. C., & Schmidt, P. (2022). Effect of Perioperative Gabapentin on Postoperative Pain Resolution and Opioid Cessation in a Mixed Surgical Cohort: A Randomized Clinical Trial (vol 153, pg 303, 2018). JAMA SURGERY, 157(6), 553. -
Use of breast MRI to distinguish treatment failure versus new primary tumor following single fraction breast intraoperative radiotherapy for breast cancer (SF-IORT).
Payne, S., Payne, S., Horst, K. C., Ikeda, D. M., & Dirbas, F. M. (2022). Use of breast MRI to distinguish treatment failure versus new primary tumor following single fraction breast intraoperative radiotherapy for breast cancer (SF-IORT). JOURNAL OF CLINICAL ONCOLOGY. LIPPINCOTT WILLIAMS & WILKINS. -
Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis.
Sikandar, S. S., Gulati, G. S., Antony, J., Fetter, I., Kuo, A. H., Ho, W. H., … Clarke, M. F. (2022). Identification of a minority population of LMO2+ breast cancer cells that integrate into the vasculature and initiate metastasis. Science Advances, 8(45), eabm3548. -
Gaseous nitric oxide tumor ablation induces an anti-tumor abscopal effect.
Confino, H., Dirbas, F. M., Goldshtein, M., Yarkoni, S., Kalaora, R., Hatan, M., … Wolf, I. (2022). Gaseous nitric oxide tumor ablation induces an anti-tumor abscopal effect. Cancer Cell International, 22(1), 405. -
Management of Local-Regional Recurrence of Breast Cancer
Hui, C., Dirbas, F. M. M., & Horst, K. C. C. (2023). Management of Local-Regional Recurrence of Breast Cancer. CURRENT BREAST CANCER REPORTS. -
Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice.
Confino, H., Sela, Y., Epshtein, Y., Malka, L., Goldshtein, M., Chaisson, S., … Dirbas, F. M. (2023). Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice. Cells, 12(20). -
Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
Singh, P., Agnese, D., Amin, M., Barrio, A. V., Botty Van den Bruele, A., Burke, E., … Boughey, J. (2024). Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. Annals of Surgical Oncology.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
- Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
- Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
- Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer
- Trial of AVB-620 in Women With Primary, Non-Recurrent Breast Cancer Undergoing Surgery
- LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
- Molecular and Cellular Analysis of Breast Cancer
- A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
Practice Locations
Stanford Women's Cancer Center Palo Alto, CA
Palo Alto, CAStanford Women's Cancer Center
900 Blake Wilbur Drive, 1st Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereBreast Cancer Program in Palo Alto Palo Alto, CA
Palo Alto, CABreast Cancer Program in Palo Alto
900 Blake Wilbur Drive, 1st Floor
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HerePatient Reviews
(209 reviews)
View More
Referring Physicians
PHYSICIAN HELPLINE
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology orders
- View referral status
- Access medical records